3D mammography, also known as tomosynthesis, found 22 percent more breast cancers and led to fewer call backs, according to a new Penn Medicine study presented by Emily F. Conant, MD, chief of Breast Imaging, at the 2013 RSNA annual meeting. Conventional mammography is the most widely-used screening modality for breast cancer, but it can miss cancers and deliver false positives. "Tomosynthesis is evolving, and this is the beginning of an exciting platform that will address many issues... it is an improvement on 2D mammography," Conant said. Still, the relatively new technique "is not the be-all and end-all," Conant told NPR. Instead, she hopes it's the beginning of an evolution toward more precise, personalized breast cancer screening. A segment on the study also ran on CBS 2 in Los Angeles and other CBS and NBC affiliates across the country. It was also covered by KYW Newsradio and MedPage Today.
Penn Medicine news release
CBS 2 Los Angeles segment
KYW Newsradio/CBSLocal.com article
MedPage Today article